New Huntington's drug enters next safety check
NCT ID NCT07344519
Summary
This is a very early study to check the safety of a new drug called ER2001 for people with early Huntington's disease. It will give 9 participants who were in a previous study weekly injections for 6 weeks to see how their bodies handle the drug and if there are any side effects. The main goal is to find a safe dose, not to prove the drug works yet.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.